Xenon Pharmaceuticals Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Xenon Pharmaceuticals Inc.
RECRUITINGPhase 3NCT05716100
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
The X-TOLE3 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101...
Sponsor: Xenon Pharmaceuticals Inc.Enrolling: 36020 locations
Focal Onset Seizures
RECRUITINGPhase 3NCT07172516
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder...
X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult participants diagnosed with...
Sponsor: Xenon Pharmaceuticals Inc.Enrolling: 40020 locations
Bipolar DisorderBipolar DepressionBipolar I Disorder+1